2,000,000 SHARES OF COMMON STOCK - SECONDARY …

ATIS and Smith & Nephew plc entered into a joint venture to globally market Dermagraft, TransCyte, and the future cartilage products. Smith & Nephew is a global healthcare company with over $1.7 billion in annual sales and a strong record of developing, manufacturing and distributing a diverse array of tissue repair products focused primarily ... ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download